Tag: Prescription Drugs
Triple Therapy Tied to Reduced Rate of COPD Exacerbations
Benefits seen for triple therapy with fluticasone furoate, umeclidinium, and vilanterol
Calcium Channel Blockers May Up Pancreatic Cancer Risk in Women
Increased hazard ratios for pancreatic cancer among postmenopausal users of short-acting CCBs
Nonoptimized Drug Therapy Costs More Than $500 Billion Annually
After initial Rx use, average cost of individual having treatment failure, new medical problem over $2,000
Adjuvant Pembrolizumab Beneficial in Stage III Melanoma
Pembrolizumab linked to significantly longer recurrence-free survival at 15-month follow-up
Endocrine Therapy-Induced Alopecia Seen in Breast Cancer
92 percent had grade 1 severity alopecia with endocrine tx; pattern similar to androgenetic alopecia
Odds of Prescribing Drugs Up With Doc Receipt of Payments
Doctors who receive general payment for cancer drug more likely to prescribe drug marketed by company
Polypharmacy Linked to Poorer Cognitive, Physical Capability
Stronger negative associations for participants with polypharmacy at age 60 to 64 years and at 69 years
Most Patients Are Unaware of Drug Cancer Shortages
Majority say they want to know about even minor consequences of cancer drug substitutions
Sirolimus May Be Beneficial in DIPNECH Syndrome
Beneficial effects seen for three women with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
Myocarditis Rare Side Effect of Immune Checkpoint Inhibitors
Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages
